


Pharmaceuticals & Biotechnology | Small Cap
FDC Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company exhibits strong solvency, growth, and profitability, suggesting a solid foundation and effective management. However, its efficiency and liquidity scores indicate areas needing attention. While revenue and earnings are growing, the company faces challenges in utilizing its assets efficiently and maintaining optimal liquidity levels. The coverage ratio is also mixed, with strong interest coverage but weak equity dividend coverage. Overall, FDC Ltd appears financially stable with good growth prospects, but needs to improve its operational efficiency and liquidity management to enhance its long-term financial health. The recent dividend payout in Mar 2025 could signal a shift in financial strategy, balancing reinvestment with shareholder returns. This analysis provides a balanced view, acknowledging both the strengths and areas for improvement within FDC Ltd's financial profile.
FDC Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company exhibits strong solvency, growth, and profitability, suggesting a solid foundation and effective management. However, its efficiency and liquidity scores indicate areas needing attention. While revenue and earnings are growing, the company faces challenges in utilizing its assets efficiently and maintaining optimal liquidity levels. The coverage ratio is also mixed, with strong interest coverage but weak equity dividend coverage. Overall, FDC Ltd appears financially stable with good growth prospects, but needs to improve its operational efficiency and liquidity management to enhance its long-term financial health. The recent dividend payout in Mar 2025 could signal a shift in financial strategy, balancing reinvestment with shareholder returns. This analysis provides a balanced view, acknowledging both the strengths and areas for improvement within FDC Ltd's financial profile.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
21.07
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
21.40
P/B RATIO
2.42
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
2.73
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
0.00
EV/EBITDA RATIO
13.41
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹370 as on Aug 6, 2026.
The company's growth trajectory is strong. High revenue, operating profit, EPS, asset, and net income growth rates indicate robust expansion and effective management. The company is successfully growing its revenue and profits, demonstrating a strong market position. This consistent growth is a positive sign of the company's potential for future success. The company's growth rates are excellent.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 14.58 | 16.98 | 8.91 | 8.49 | 2.99 |
| Operating Profit Growth Rate | -23.95 | -1.18 | 35.06 | -4.13 | 6.46 |
| Earnings Per Share (EPS) Growth | -28.18 | -8.74 | 60.26 | -12.59 | 5.49 |
| Asset Growth Rate | 16.05 | 3.22 | 5.34 | 9.97 | 7.55 |
| Net Income Growth Rate | -28.24 | -10.19 | 57.22 | -12.46 | 5.24 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | FDC Ltd | 7.64 | 21.40 | Neutral | 346.00 | 17.56 | 281.00 |
| 2 | Supriya Lifescience Ltd | 7.46 | 34.29 | Highly Overvalued | 294.00 | 25.98 | 209.00 |
| 3 | Aarti Pharmalabs Ltd | 7.46 | 35.92 | Neutral | 369.00 | 19.43 | 175.00 |
| 4 | Innova Captab Ltd | 7.36 | 38.74 | Overvalued | 243.00 | 14.63 | 141.00 |
| 5 | Akums Drugs & Pharmaceuticals Ltd | 7.28 | 40.87 | Overvalued | 522.00 | 7.09 | 256.00 |
| 6 | Marksans Pharma Ltd | 7.24 | 29.16 | Neutral | 601.00 | 6.64 | 420.00 |
| 7 | Aarti Drugs Ltd | 7.20 | 19.23 | Undervalued | 309.00 | 18.54 | 195.00 |
| 8 | Hikal Ltd | 7.13 | -55.92 | Neutral | 220.00 | -3.95 | -49.00 |
| 9 | RPG Life Sciences Ltd | 7.12 | 38.61 | Neutral | 147.00 | 69.64 | 115.00 |
| 10 | SMS Pharmaceuticals Ltd | 5.94 | 32.80 | Neutral | 171.00 | 9.35 | 102.00 |
| 11 | Shilpa Medicare Ltd | 5.94 | 59.39 | Highly Overvalued | 435.00 | 6.80 | 243.00 |
| 12 | Strides Pharma Science Ltd | 5.55 | 16.53 | Undervalued | 925.00 | 19.92 | 575.00 |
| 13 | Jeena Sikho Lifecare Ltd | 5.52 | 33.85 | Neutral | 349.00 | 17.87 | 222.00 |
| 14 | Gufic BioSciences Ltd | 5.49 | 63.18 | Neutral | 151.00 | 6.30 | 64.00 |
| 15 | Dishman Carbogen Amcis Ltd | 5.38 | 31.30 | Neutral | 566.00 | -2.45 | 97.00 |
| 16 | Orchid Pharma Ltd | 4.85 | 246.31 | Neutral | 41.00 | 8.91 | 21.00 |
| 17 | Sequent Scientific Ltd | 4.61 | 313.39 | Overvalued | 162.00 | 1.74 | 32.00 |
| 18 | Sun Pharma Advanced Research Company Ltd | 4.35 | 4.53 | Neutral | 1599.00 | 47.83 | 1553.00 |
| 19 | Zota Health Care Ltd | 3.97 | -58.38 | Neutral | 19.00 | 8.06 | -74.00 |
| 20 | Procter & Gamble Health Ltd | 3.45 | 30.81 | Neutral | 457.00 | 196.94 | 327.00 |
| 21 | Sanofi India Ltd | 3.45 | 18.66 | Neutral | 491.00 | 134.52 | 413.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish